全文获取类型
收费全文 | 95657篇 |
免费 | 30029篇 |
国内免费 | 1063篇 |
专业分类
耳鼻咽喉 | 2373篇 |
儿科学 | 2655篇 |
妇产科学 | 2283篇 |
基础医学 | 2293篇 |
口腔科学 | 5018篇 |
临床医学 | 25771篇 |
内科学 | 24163篇 |
皮肤病学 | 3226篇 |
神经病学 | 12016篇 |
特种医学 | 3579篇 |
外科学 | 17728篇 |
综合类 | 210篇 |
现状与发展 | 40篇 |
一般理论 | 1篇 |
预防医学 | 13440篇 |
眼科学 | 2117篇 |
药学 | 1108篇 |
中国医学 | 8篇 |
肿瘤学 | 8720篇 |
出版年
2024年 | 740篇 |
2023年 | 5016篇 |
2022年 | 1072篇 |
2021年 | 2657篇 |
2020年 | 5279篇 |
2019年 | 1940篇 |
2018年 | 6794篇 |
2017年 | 7282篇 |
2016年 | 7836篇 |
2015年 | 7914篇 |
2014年 | 10312篇 |
2013年 | 11962篇 |
2012年 | 3521篇 |
2011年 | 3272篇 |
2010年 | 6676篇 |
2009年 | 8975篇 |
2008年 | 3285篇 |
2007年 | 2198篇 |
2006年 | 3425篇 |
2005年 | 1955篇 |
2004年 | 1360篇 |
2003年 | 1060篇 |
2002年 | 970篇 |
2001年 | 1894篇 |
2000年 | 1187篇 |
1999年 | 1710篇 |
1998年 | 2065篇 |
1997年 | 1893篇 |
1996年 | 1949篇 |
1995年 | 1690篇 |
1994年 | 1086篇 |
1993年 | 908篇 |
1992年 | 779篇 |
1991年 | 676篇 |
1990年 | 554篇 |
1989年 | 559篇 |
1988年 | 553篇 |
1987年 | 436篇 |
1986年 | 403篇 |
1985年 | 352篇 |
1984年 | 302篇 |
1983年 | 325篇 |
1982年 | 249篇 |
1981年 | 211篇 |
1980年 | 133篇 |
1979年 | 113篇 |
1978年 | 158篇 |
1977年 | 142篇 |
1974年 | 114篇 |
1972年 | 120篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Oulimata Dieng MD Valerie Laurence MD Christelle Logerot PhD Youlia M. Kirova MD 《The breast journal》2021,27(10):787-790
Eribulin is widely used in the treatment of metastatic breast cancer, with a manageable toxicity profile. This aggressive disease often requires systemic and local treatments, comprising surgery or radiotherapy. However, eribulin is usually discontinued during radiation therapy due to the lack of data concerning the safety of this combination, especially in the setting of repeat locoregional radiation therapy. Our patient was diagnosed with ER positive invasive ductal carcinoma of the left breast initially treated by surgery, radiation therapy, chemotherapy, and hormone therapy. She then received various lines of chemotherapy for multiple triple-negative relapses in the left axillary region. Since October 2020, she has been treated by eribulin. In order to improve local control, it was decided to add local radiation therapy to the region of recurrence in addition to systemic therapy. She underwent radiation therapy concomitantly with eribulin from February to March 2021. Treatment was very well tolerated, and no acute toxicity was reported. This is the first published case of repeat locoregional radiation therapy in combination with eribulin. 相似文献
992.
Ida Micaily MD Hannah Hackbart Meghan Butryn PhD Maysa M. Abu-Khalaf MD 《The breast journal》2021,27(7):603-607
Obesity is a modifiable risk factor in breast cancer patients and is predictive of disease outcomes in early-onset breast cancer survivors. The purpose of this review is to summarize the current evidence in the association between early-onset breast cancer and obesity, specifically in African-American women. Reviewing the molecular mechanisms and social determinants of disease in this population can provide a foundation for future interventions in prevention, detection, and treatment aiming at improving outcomes for young breast cancer patients. 相似文献
993.
Gerson M. Struik MSc MD PhD Bram Schermers MSc Ingeborg Mares MSc MD PhD Harold E. Lont MSc MD Jennifer W. Bradshaw MSc MD Bernard ten Haken MSc Ir PhD Theo J. M. Ruers MSc MD PhD Jurgen E. M. Mourik PhD Erwin Birnie MSc PhD Taco M. A. L. Klem MSc MD PhD 《The breast journal》2021,27(8):638-650
Wire-guided localization (WGL) is the standard of care in the surgical treatment of nonpalpable breast tumors. In this study, we compare the use of a new magnetic marker localization (MaMaLoc) technique to WGL in the treatment of early-stage breast cancer patients. Open-label, single-center, randomized controlled trial comparing MaMaLoc (intervention) to WGL (control) in women with early-stage breast cancer. Primary outcome was surgical usability measured using the System Usability Scale (SUS, 0–100 score). Secondary outcomes were patient reported, clinical, and pathological outcomes such as retrieval rate, operative time, resected specimen weight, margin status, and reoperation rate. Thirty-two patients were analyzed in the MaMaLoc group and 35 in the WGL group. Patient and tumor characteristics were comparable between groups. No in situ complications occurred. Retrieval rate was 100% in both groups. Surgical usability was higher for MaMaLoc: 70.2 ± 8.9 vs. 58.1 ± 9.1, p < 0.001. Patients reported higher overall satisfaction with MaMaLoc (median score 5/5) versus WGL (score 4/5), p < 0.001. The use of magnetic marker localization (MaMaLoc) for early-stage breast cancer is effective and has higher surgical usability than standard WGL. 相似文献
994.
Tammy Ju MD Deshka Foster MD PhD Ashley Titan MD Saleh Najjar MD Gregory R. Bean MD PhD Kristen Ganjoo MD Irene Wapnir MD 《The breast journal》2021,27(9):723-725
Radiation-induced breast angiosarcoma, or secondary angiosarcoma (SAS), is a rare entity with a high risk of metastatic recurrence. Herein, we describe the use of intraoperative fluorescence-based skin angiography to guide surgical resection following a novel immunotherapy-based regimen for SAS resulting in a complete pathological response. 相似文献
995.
Nobuyoshi Kittaka MD PhD Satomi Nakajima MD Takaaki Hatano MD Yukiko Seto MD Hiroki Kusama MD PhD Saki Matsui MD PhD Minako Nishio MD PhD Fumie Fujisawa MD PhD Keiichiro Honma MD PhD Takahiro Nakayama MD PhD Yasuhiro Tamaki MD PhD 《The breast journal》2021,27(11):804-810
The ACOSOG Z0011 trial has resulted in the omission of axillary lymph node dissection (ALND) in early breast cancer patients with one or two metastatic sentinel lymph nodes (SLNs). There has been increasing interest in the necessity of intraoperative assessment of SLNs in patients treated based on the Z0011 criteria. We evaluated the utility of intraoperative assessment in these eligible patients. A total of 1396 patients were treated following the Z0011 criteria from April 2012 to December 2019. We examined the proportion and clinicopathological features of patients who underwent ALND due to three or more metastatic SLNs and the sensitivity of intraoperative assessment. Only 16 (1.1%) patients had three or more metastatic SLNs diagnosed by intraoperative assessment, and they immediately underwent ALND. Of the clinicopathological factors, high clinical tumor stage (p = 0.002) and high Ki-67 labeling index value (p = 0.056) were more likely to be associated with the presence of three or more metastatic SLNs. The major independent risk factor for three or more metastatic SLNs was high clinical tumor stage (OR 3.94 [95% CI 1.42–11.0]; p = 0.009). Intraoperative assessment had low sensitivity (70.5%) and a high false-negative rate (29.5%) in detecting SLN metastases. The main finding of our study was the small proportion of patients who required ALND due to three or more metastatic SLNs according to the Z0011 criteria. The Z0011 strategy enables intraoperative assessment of SLNs to be omitted in early breast cancer patients. 相似文献
996.
997.
Lucie Matrat MD Mathias Ruiz MD Emmanuelle Ecochard-Dugelay MD Irène Loras-Duclaux MD Stéphanie Marotte MD Sophie Heissat MD Pierre Poinsot MD Anne-Laure Sellier-Leclerc MD Justine Bacchetta MD PhD Laurence Dubourg MD PhD Noël Peretti MD PhD 《JPEN. Journal of parenteral and enteral nutrition》2022,46(1):180-189
998.
999.
1000.